Medications

Elan enters $1B royalty deal with Theravance

Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline.

Neuroscience

Study finds US facing neurologist shortage

Americans with brain diseases such as Alzheimer's disease, Parkinson's disease or multiple sclerosis (MS) who need to see a neurologist may face longer wait times or have more difficulty finding a neurologist, according to ...

Obstetrics & gynaecology

ACA dependent coverage tied to increased prenatal care

(HealthDay)—The Affordable Care Act dependent coverage provision is associated with increased early and adequate prenatal care and decreased preterm births, according to a study published in the Feb. 13 issue of the Journal ...

Health

Fiscal standoff could cause financial pain for health care

(HealthDay)—"Sequestration" is Washington-speak for the approximately $85 billion in annual federal spending cuts mandated by the Budget Control Act of 2011. Those cuts were originally set to take effect on Jan. 1, but ...

Health

Report: Higher premiums if Trump halts 'Obamacare' subsidies

Premiums for a popular type of individual health plan would rise sharply, and more people would be left with no insurance options if President Donald Trump makes good on his threat to stop "Obamacare" payments to insurers, ...

page 14 from 25